Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain

Pain Physician

Volumn 14, Issue 3, 2011, Pages

  Deer, Timothy R ^a   Smith, Howard S ^b   Burton, Allen ^c   Pope, Jason ^a   Doleys, Daniel ^d   Levy, Robert M ^e   Staats, Peter S ^f   Wallace, Mark ^g   Webster, Lynn R ^h   Rauck, Richard ⁱ   Cousins, Michael ^j  

^a Center for Pain Relief Inc   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e Pain and Rehabilitation Institute   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Lifetree Clinical Research and Pain Clinic   (United States)

^j WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

more..

Author keywords

Cancer; Consensus; Evidence; Guidelines; Intrathecal; Opioids; Pain; Palliative; Selection

Indexed keywords

ADENOSINE; BACLOFEN; BEVACIZUMAB; BUPIVACAINE; BUPRENORPHINE; CLONIDINE; CLOPIDOGREL; FENTANYL; GABAPENTIN; HEPARIN; HYDROMORPHONE; KETOROLAC; LOW MOLECULAR WEIGHT HEPARIN; MIDAZOLAM; MORPHINE; NEOSTIGMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; OMEGA CONOTOXIN CVID; OMEGA CONOTOXIN MVIIA; OPIATE; OXYCODONE; PERCOCET; PETHIDINE; PLACEBO; ROPIVACAINE; SUFENTANIL; TICLOPIDINE; UNINDEXED DRUG; WARFARIN;

ABSENCE OF SIDE EFFECTS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ANALGESIA; BLEEDING; BLOOD CLOTTING DISORDER; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; COMORBIDITY; CONSENSUS DEVELOPMENT; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DOSE TITRATION; DRUG IMPLANTATION; DRUG RESPONSE; ECONOMIC ASPECT; EPIDURAL HEMATOMA; GRANULOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOCOMPROMISED PATIENT; LIFE EXPECTANCY; LUNG EMBOLISM; METASTASIS POTENTIAL; MONOTHERAPY; NERVE CELL LESION; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NOCICEPTION; NONREM SLEEP; OBESITY; PAIN; PAIN ASSESSMENT; PATIENT SELECTION; PREVALENCE; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; REIMBURSEMENT; RESPIRATION DEPRESSION; REVIEW; SINGLE DRUG DOSE; SKIN BRUISING; SLEEP APNEA SYNDROME; SOCIAL SUPPORT; SPINE METASTASIS; SURGICAL INFECTION; THROMBOCYTE COUNT; VENOUS THROMBOEMBOLISM; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

ANALGESICS; EVIDENCE-BASED MEDICINE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; NEOPLASMS; PAIN, INTRACTABLE;

EID: 79957872951     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (240)

1. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007; 18:1437-1449.
2. Manchikanti L. Singh V, Datta S, Cohen SP, Hirsch JA. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009; 12:E35-E70.
3. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D. Intrathe-cal ziconotide in the treatment of refractory pain in patients with cancer or AIDS. JAMA 2004; 291:63-70.
4. Smith TJ, Staats, PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Coyne PJ, Pool GE; Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002; 20:4040-4049.
5. Smith TJ, Coyne PJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchs-er E, Català E, Bryce DA, Cousins M, Pool GE. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 2005; 16:825-833.
6. Deer T, Krames ES, Hassenbusch SJ, Burton, A., Caraway, D., Dupen, S., Eisenach, J., Erdek, M., Grigsby, E., Kim, P., Levy, R., McDowell, G., Mekhail, N., Panchal, S., Prager, J., Rauck, R., Saulino, M., Sitzman, T., Staats, P., Stanton-Hicks, M., Stearns, L., Willis, K. D., Witt, W., Follett, K., Huntoon, M., Liem, L., Rathmell, J., Wallace, M., Buchser, E., Cousins, M. and Ver Donck, A. Polyanalgesic Consensus Conference 2007: recommendations for the management of pain by intrathecal (intra-spinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation 2007; 10:300-328.
7. Burton AW, Rajagopal A, Shah HN, Men- doza T, Cleeland C, Hassenbusch SJ 3rd, Arens JF. Epidural and intrathecal analge sia is effective in treating refractory cancer pain. Pain Medicine 2004; 5:239-247.
8. Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, Herbst L, Kiser J. Intrathecal drug delivery for the management of cancer pain: A multidisci-plinary consensus of best clinical practices. J Support Oncol 2005; 3:399-408.
9. Foley KM. Acute and chronic cancer pain syndromes. In Doyle D, Hanks G, Cherny N, Calman K (eds). Oxford Textbook of Palliative Medicine 3rd ed. Oxford University Press, Oxford, United Kingdom, 2004, pp 298-316.
10. Krakovsky AA. Complications associated with intrathecal pump drug delivery: A retrospective evaluation. Am J Pain Manag 2007; 17:4-10.
11. Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K. Long-term intrathecal opi-oid therapy with a patient-activated, implanted delivery system for the treatment of cancer pain. J Pain 2003; 4:441-447.
12. Becker R, Jakob D, Uhle E, Riegel T, Ber-talanffy H. The significance of intrathecal opioid therapy for the treatment of neuropathic cancer pain conditions. Stereotact Funct Neurosurg 2000; 75:16-26.
13. Ghafoor VL, Epshteyn M, Carlson GH, Terhaar DM, Chany O, Phelps PK. Intra-thecal drug therapy for long-term pain management. Am J Health Syst Pharm 2007; 64:2447-2461.
14. Belverud A, Mogilner A, Schulder M. In-trathecal pumps. Neurotherapeutics 2008; 5:114-122.
15. Walker SM, Goudas LC, Cousins MJ, Carr DB. Combination spinal analgesic chemotherapy: A systematic review. Anesth Analg 2002; 95:674-715.
16. Siddall PJ, Molloy AR, Walker S, Rutkows-ki SB, Cousins MJ. The efficacy of intrathe-cal morphine and clonidine in the treatment of pain after spinal cord injury. Anes-th Analg 2000; 91:1493-1498.
17. Rainov NG, Heidecke V, Burker W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001; 22:862-871.
18. Wallace MS, Kosek PS, Staats P, Fisher R, Schultz DM, Leong M. Phase II, open-label, multicenter study of combined intra-thecal morphine and ziconotide: Addition of ziconotide in patients receiving intra-thecal morphine for severe chronic pain. Pain Med 2008; 9:271-281.
19. Deer TR, Krames E, Levy RM, Hassen-busch SJ, Prager JP. Practice choices and challenges in the current intrathecal therapy environment: An online survey. Pain Med 2009; 10:304-309.
20. Smith HS, Deer TR. Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain. Ther Clin Risk Man-ag 2009; 5: 521-534. Epub 2009 Jul 12.
21. Deer T, Winkelmuller W, Erdine S, Bedder M, Burchiel K. Intrathecal therapy for cancer and nonmalignant pain: Patient selection and patient management. Neuro-modulation 1999; 2:55-66.
22. Deer T, Chapple I, Classen A, Javery K, Stoker V, Tonder L, Burchiel K. Intrathe-cal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Med 2004; 5:6-13.
23. Appelgren L, Nordbong C, Sjoberg M, Karlsson PA, Nitescu P, Curelasu I. Spinal epidural metastasis: Implications for spinal analgesia to treat "refractory" cancer pain. J Pain Symptom Manage 1997; 13:25-42.
24. Follet KA, Boortz-Marx RL, Drake JM, DuPen S, Schneider SJ, Turner MS, Coffey RJ. Prevention and management of intra-thecal drug delivery and spinal cord stimulation system infections. Anesthesiology 2004; 100:1582-1594.
25. ® intrathecal infusion pump. Pain Med 2009; 10:124.
26. ® intrathecal infusion pump. A prospective multi-center evaluation. Poster presented at: 5th World Congress Institute of Pain; March 15, 2009; New York, NY.
27. Ilias W, Polain B, Buchser E, Demartini L. Patient-controlled analgesia in chronic pain patients: Experience with a new device designed to be used with implanted programmable pumps. Pain Pract 2008; 8:164-170.
28. Wallace MS, Rauck R, Fisher R, Charapa-ta SG, Ellis D, Dissanayake S. Intrathecal ziconotide for severe chronic pain: Safety and tolerability results of an open-label, long-term trial. Anesth Analg 2008; 106:628-637.
29. Rauck RL, Wallace MS, Leong MS, Mine-hart M, Webster LR, Charapata SG, Abraham JE, Buffington DE, Ellis D, Kartzinel R; Ziconotide 301 Study Group. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006; 31:393-406.
30. Wallace MS, Charapata SG, Fisher R, Byas-Smith M, Staats P, Mayo M, Mc-Guire D, Ellis D. Intrathecal ziconotide in the treatment of chronic nonmalignant pain: A randomized, double-blind, placebo-controlled clinical trial. Neuromodula-tion 2006; 9:75-86.
31. Webster LR, Fisher R, Charapata S, Wallace MS. Long-term intrathecal ziconotide for chronic pain: An open-label study. J Pain Symptom Manage 2009; 37:363-372.
32. Canavero S, Bonicalzi V, Clemente M. No neurotoxicity from long-term (>5 years) intrathecal infusion of midazolam in humans. J Pain Symptom Manage 2006; 32:1-3.
33. Yaksh TL, Allen JW. The use of intrathe-cal midazolam in humans: A case study of process. Anesth Analg 2004; 98:1536-1545
34. Knight KH, Brand FM, Mchaourab AS, Veneziano G. Implantable intrathecal pumps for chronic pain: Highlights and updates. Croat Med J 2007; 48:22-34.
35. Sosnowski M, Yaksh TL. Role of spinal ad-enosine receptors in modulating the hy-peresthesia produced by spinal glycine receptor antagonism. Anesth Analg 1989; 69:587-592.
36. Lee YW, Yaksh TL. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther 1996; 277:1642-1648.
37. Karlsten R, Gordh T Jr., An A1-selective ad-enosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 1995; 80:844-847.
38. Rane K, Segerdahl M, Goiny M, Sollevi A. Intrathecal adenosine administration: A phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology 1998; 89:1108-1115.
39. Belfrage M, Segerdahl M, Arnér S, Sollevi A. The safety and efficacy of intrathecal ad-enosine in patients with chronic neuropathic pain. Anesth Analg 1999; 89:136-142.
40. Coderre TJ, Kumar N, Lefebvre CD, Yu JSC. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 2005; 94:1131-1139.
41. Field MJ, Hughes J, Singh L. Further evidence for the role of the alpha(2)delta sub-unit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000; 131:282-286.
42. Cheng JK, Chen CC, Yang JR, Chiou LC. The antiallodynic action target of intra-thecal gabapentin: Ca2+ channels, KATP channels or N-methyl-d-aspartic acid receptors? Anesth Analg 2006; 102:182-187.
43. Hayashida K, Obata H, Nakajima K, Eisenach JC. Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology 2008; 109:1077-1084.
44. Van Elstraete AC, Sitbon P, Mazoit JX, Benhamou D. Gabapentin prevents delayed and long-lasting hyperalgesia induced by fentanyl in rats. Anesthesiology 2008; 108:484-494.
45. Lin JA, Lee MS, Wu CT, Yeh CC, Lin SL, Wen ZH, Wong CS. Attenuation of morphine tolerance by intrathecal gabapen-tin is associated with suppression of morphine-evoked excitatory amino acid release in the rat spinal cord. Brain Res 2005; 1054:167-173.
46. Granados-Soto V, Arguelles CF. Synergic antinociceptive interaction between tra-madol and gabapentin after local, spinal, and systemic administration. Pharmacology 2005; 74:200-208.
47. Kroin JS, Ling ZD, Buvanendran A, Tuman KJ. Upregulation of spinal cyclooxygen-ase-2 in rats after surgical incision. Anes-thesiology 2004; 100:364-369.
48. Yaksh TL, Horais KA, Tozier N, Rathbun M, Richter P, Rossi S, Grafe M, Tong C, Meschter C, Cline JM, Eisenach J. Intra-thecal ketorolac in dogs and rats. Toxicol Sci 2004; 80:322-334.
49. Szabo T, Olah Z, Iadarola MJ, Blumberg PM. Epidural resiniferatoxin induced prolonged regional analgesia to pain. Brain Res 1999; 840:92-98.
50. Brown DC, Iadarola MJ, Perkowski SZ, Erin H, Shofer F, Laszlo KJ, Olah Z, Mannes AJ. Physiologic and antinocicep-tive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiolo-gy 2005; 103:1052-1059.
51. Allen JW, Mantyh PW, Horais K, Tozier N, Rogers SD, Ghilardi JR, Cizkova D, Grafe MR, Richter P, Lappi DA, Yaksh TL. Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs. Toxicol Sci 2006; 91:286-298.
52. Wiley RG. Substance P receptor-expressing dorsal horn neurons: Lessons from the targeted cytotoxin, substance P-sapo-rin. Pain 2008; 136:7-10.
53. Resiniferatoxin to treat severe pain associated with advanced cancer. Clini-calTrials.gov. clinicaltrials.gov/ct2/show/NCT00804154. Accessed September 22, 2009.
54. Deer TR, Smith HS, Cousins M, Dolevs DM, Levy RM, Rathmell JP. Consensus guidelines for the selection and implantation of patients with noncancerk pain for intrathecal drug delivery. Pain Physician 2010; 13:E175-E213.
55. Manchikanti L, Boswell MV, Singh V, Be-nyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJE, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician 2009; 12:699-802.
56. Manchikanti L, Boswell MV, Singh V, Derby R, Fellows B, Falco FJE, Datta S, Smith HS, Hirsch JA. Comprehensive review of neurophysiologic basis and diagnostic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E71-E120.
57. Manchikanti L, Boswell MV, Datta S, Fellows B, Abdi S, Singh V, Benyamin RM, Falco FJE, Helm S, Hayek S, Smith HS. Comprehensive review of therapeutic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E123-E198.
58. Manchikanti L, Helm S, Singh V, Benya-min RM, Datta S, Hayek S, Fellows B, Bo-swell MV. An algorithmic approach for clinical management of chronic spinal pain. Pain Physician 2009; 12:E225-E264.
59. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V, Fellows B. Comparative effectiveness of a one-year follow-up of thoracic medial branch blocks in management of chronic thoracic pain: A randomized, double-blind active controlled trial. Pain Physician 2010; 13:535-548.
60. Manchikanti L, Singh V, Falco FJ, Cash KA, Fellows B. Cervical medial branch blocks for chronic cervical facet joint pain: A randomized double-blind, controlled trial with one-year follow-up. Spine (Phila Pa 1976) 2008; 33:1813-1820.
61. Manchikanti L, Singh V, Falco FJE, Cash KA, Fellows B. Comparative outcomes of a 2-year follow-up of cervical medial branch blocks in management of chronic neck pain: A randomized, double-blind controlled trial. Pain Physician 2010; 13:437-450.
62. Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V. Lumbar facet joint nerve blocks in managing chronic facet joint pain: One-year follow-up of a randomized, double-blind controlled trial: Clinical Trial NCT00355914. Pain Physician 2008; 11:121-132.
63. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of lumbar facet joint nerve blocks in managing chronic low back pain: A randomized, double-blind, controlled trial with a 2-year follow-up. Int J Med Sci 2010; 7:124-135.
64. Manchikanti L, Cash RA, McManus CD, Pampati V, Fellows B. Fluoroscopic caudal epidural injections with or without steroids in managing pain of lumbar spinal stenosis: One year results of randomized, double-blind, active-controlled trial. J Spinal Disord 2011; accepted for publication.
65. Manchikanti L, Singh V, Cash KA, Pampa-ti V, Damron KS, Boswell MV. A randomized, controlled, double-blind trial of fluo-roscopic caudal epidural injections in the treatment of lumbar disc herniation and radiculitis. Spine (Phila Pa 1976) 2011; accepted for publication.
66. Manchikanti L, Cash KA, Pampati V, War-go BW, Malla Y. Cervical epidural injections in chronic discogenic neck pain without disc herniation or radiculitis: Preliminary results of a randomized, double-blind, controlled trial. Pain Physician 2010; 13:E265-E278.
67. Manchikanti L, Cash KA, Pampati V, War-go BW, Malla Y. The effectiveness of fluo-roscopic cervical interlaminar epidural injections in managing chronic cervical disc herniation and radiculitis: Preliminary results of a randomized, double-blind, controlled trial. Pain Physician 2010; 13:223-236.
68. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of the effectiveness of lumbar interlaminar epidural injections in managing chronic pain of lumbar disc herniation or radiculitis: A randomized, double-blind, controlled trial. Pain Physician 2010; 13:343-355.
69. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. A preliminary report of a randomized double-blind, active controlled trial of fluoroscopic thoracic interlaminar epidural injections in managing chronic thoracic pain. Pain Physician 2010; 13:E357-E369.
70. Manchikanti L, Cash KA, McManus CD, Pampati V, Smith HS. One year results of a randomized, double-blind, active controlled trial of fluoroscopic caudal epidural injections with or without steroids in managing chronic discogenic low back pain without disc herniation or radiculitis. Pain Physician 2011; 14:25-36.
71. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. Preliminary results of a randomized, double-blind, controlled trial of fluoroscopic lumbar inter-laminar epidural injections in managing chronic lumbar discogenic pain without disc herniation or radiculitis. Pain Physician 2010; 13:E279-E292
72. Manchikanti L, Singh V, Cash KA, Pam-pati V, Datta S. Management of pain of post lumbar surgery syndrome: One-year results of a randomized, double double-blind, active controlled trial of fluoroscopic caudal epidural injections. Pain Physician 2010; 13:509-521.
73. Manchikanti L, Cash KA, McManus CD, Pampati V, Singh V, Benyamin RM. The preliminary results of a comparative effectiveness evaluation of adhesiolysis and caudal epidural injections in managing chronic low back pain secondary to spinal stenosis: A randomized, equivalence controlled trial. Pain Physician 2009; 12:E341-E354.
74. Manchikanti L, Singh V, Cash KA, Pampa-ti V, Datta S. A comparative effectiveness evaluation of percutaneous adhesiolysis and epidural steroid injections in managing lumbar post surgery syndrome: A randomized, equivalence controlled trial. Pain Physician 2009; 12:E355-E368.
75. Patel VB, Manchikanti L, Singh V, Schul-tz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
76. Falco FJE, Erhart S, Wargo BW, Bryce DA, Atluri S, Datta S, Hayek SM. Systematic review of diagnostic utility and therapeutic effectiveness of cervical facet joint interventions. Pain Physician 2009; 12:323-344.
77. Datta S, Lee M, Falco FJE, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions. Pain Physician 2009; 12:437-460.
78. Conn A, Buenaventura R, Datta S, Abdi S, Diwan S. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009; 12:109-135.
79. Parr AT, Diwan S, Abdi S. Lumbar inter-laminar epidural injections in managing chronic low back and lower extremity pain: A systematic review. Pain Physician 2009; 12:163-188.
80. Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician 2009; 12:137-157.
81. Buenaventura RM, Datta S, Abdi S, Smith HS. Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Physician 2009; 12:233-251.
82. Rupert MP, Lee M, Manchikanti L, Datta S, Cohen SP. Evaluation of sacroiliac joint interventions: A systematic appraisal of the literature. Pain Physician 2009; 12:399-418.
83. Hayek SM, Helm S, Benyamin RM, Singh V, Bryce DA, Smith HS. Effectiveness of spinal endoscopic adhesiolysis in post lumbar surgery syndrome: A systematic review. Pain Physician 2009; 12:419-435.
84. Epter RS, Helm S, Hayek SM, Benyamin RM, Smith HS, Abdi S. Systematic review of percutaneous adhesiolysis and management of chronic low back pain in post lumbar surgery syndrome. Pain Physician 2009; 12:361-378.
85. Helm S, Hayek S, Benyamin RM, Manchikanti L. Systematic review of the effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician 2009; 12:207-232.
86. Hirsch JA, Singh V, Falco FJE, Benyamin RM, Manchikanti L. Automated percutaneous lumbar discectomy for the contained herniated lumbar disc: A systematic assessment of evidence. Pain Physician 2009; 12:601-620.
87. Singh V, Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Percutaneous lumbar laser disc decompression: A systematic review of current evidence. Pain Physician 2009; 12:573-588.
88. Singh V, Benyamin RM, Datta S, Falco FJE, Helm S, Manchikanti L. Systematic review of percutaneous lumbar mechanical disc decompression utilizing Dekompressor. Pain Physician 2009; 12:589-599.
89. Manchikanti L, Derby R, Benyamin RM, Helm S, Hirsch JA. A systematic review of mechanical lumbar disc decompression with nucleoplasty. Pain Physician 2009; 12:561-572.
90. Manchikanti L, Glaser S, Wolfer L, Derby R, Cohen SP. Systematic review of lumbar discography as a diagnostic test for chronic low back pain. Pain Physician 2009; 12:541-559.
91. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: A systematic review. Pain Physician 2009; 12:379-397.
92. Manchikanti L, Derby R, Benyamin RM, Helm S, Hirsch JA. A systematic review of mechanical lumbar disc decompression with nucleoplasty. Pain Physician 2009; 12:561-572.
93. Manchikanti L, Dunbar EE, Wargo BW, Shah RV, Derby R, Cohen SP. Systematic review of cervical discography as a diagnostic test for chronic spinal pain. Pain Physician 2009; 12:305-321.
94. Smith H, Navani A, Fishman SM. Radio-pharmaceuticals for palliation of painful osseous metastases. Am J Hosp Palliat Care 2004; 21:303-313.
95. Portenoy RK, Forbes K, Lussier D, Hanks G. Difficult pain problems: An integrated approach. In Doyle D, Hanks G, Cherny N, Calman K (eds). Oxford Textbook of Palliative Medicine 3rd ed. Oxford University Press, Oxford, United Kingdom, 2004, pp 438-458.
96. Davies A. Current thinking cancer breakthrough pain management. Eur J Palliat Care 2005; 12:4-6.
97. Portenoy RK, Hagen NA. Breakthrough pain: Definition, prevalence and characteristics. Pain 1990; 41:273-281.
98. Fine PG, Busch MA. Characterization of breakthrough pain by hospice patients and their caregivers. J Pain Sympt Manage 1998; 16:179-183.
99. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: Characteristics and impact in patients with cancer pain. Pain 1999; 81:129-134.
100. Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Sympt Manage 2000; 20:87-92.
101. Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 2002; 3:38-44.
102. Gómez-Batitse X, Madrid F, Moreno F, Gracia A, Trelis J. Nabal M, Alcalde R, Pla-nas J, Camell H. Breakthrough cancer pain: Prevalence and characteristics in patients in Catalonia, Spain. J Pain Symp Manage 2002; 24:45-52.
103. Fortner BV, Demarco G, Irving G, Ashley J, Keppler G, Chavez J, Munk J. Description and predictors of direct and indirect costs of pain reported by cancer patients. J Pain Sympt Manage 2003; 25:9-18.
104. Hwang SS, Cheng VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 2003; 101:55-64.
105. Colleau SM. Breakthrough (episodic) vs. baseline (persistent) pain in cancer. Cancer Pain Release 2004; 17:1-3.
106. Caraceni A, Martini C, Zecca E, Portenoy RK, Ashby MA, Hawson G, Jackson KA, Lickiss N, Muirden N, Pisasale M, Moulin D, Schulz VN, Rico Pazo MA, Serrano JA, Andersen H, Henriksen HT, Mejholm I, Sjogren P, Heiskanen T, Kalso E, Pere P, Poyhia R, Vuorinen E, Tigerstedt I, Ruis-maki P, Bertolino M, Larue F, Ranchere JY, Hege-Scheuing G, Bowdler I, Helbing F, Kostner E, Radbruch L, Kastrinaki K, Shah S, Vijayaram S, Sharma KS, Devi PS, Jain PN, Ramamani PV, Beny A, Brunelli C, Maltoni M, Mercadante S, Plancarte R, Schug S, Engstrand P, Ovalle AF, Wang X, Alves MF, Abrunhosa MR, Sun WZ, Zhang L, Gazizov A, Vaisman M, Rudoy S, Gomez Sancho M, Vila P, Trelis J, Chaudakshetrin P, Koh ML, Van Dongen RT, Vielvoye-Kerkmeer A, Boswell MV, Elliott T, Hargus E, Lutz L; Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliative Med 2004; 18:177-183.
107. Portenoy RK. Supportive and palliative care. In:Straud DJ(ed). Educational Review Manual in Medical Oncology. Castle Connolly Graduate Medical Publishing, New York, New York, 2007, pp 361-408.
108. Patel VB, Manchikanti L, Singh V, Schul-tz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
109. Raffaeli W, Sarti D, Demartini L, Sotgiu A, Bonezzi C; Italian Ziconotide Group. Italian Registry on long-term intrathecal zi-conotide treatment. Pain Physician 2011; 14:15-24.
110. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347:143-147.
111. Molloy AR, Nicholas MK, Asghari A, Beeston LR, Dehghani M, Cousins MJ, Brooker C, Tonkin L. Does a combination of intensive cognitive-behavioral pain management and a spinal implantable device confer any advantage? A preliminary examination. Pain Pract 2006; 6:96-103.
112. Cohen SP, Dragovich A. Intrathecal analgesia. Anesthesiology Clin 2007; 25:863-882.
113. Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic nonmalignant pain: A 3-year prospective study. Pain 2004; 109:242-249.
114. Wallace M, Yaksh TL. Long-term spinal analgesic delivery: Review of the preclin-ical and clinical literature. Reg Anesth Pain Med 2000; 25:117-157.
115. Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante FM, Schultz DM, Stearns LJ, Turner MS. Mortality associated with implantation and management of intrathe-cal opioid drug infusion systems to treat noncancer pain. Anesthesiology 2009; 111:881-891.
116. Rathmell JP, Miller MJ. Death after initiation of intrathecal drug therapy for chronic pain: Assessing risk and designing prevention. Anesthesiology 2009; 111:706-708.
117. Roberts LJ, Finch PM, Pullan PT, Bhagat CI, Price LM. Sex hormone suppression by intrathecal opioids: A prospective study. Clin J Pain 2002; 18:144-148.
118. Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalig-nant pain. J Pain 2008; 9:28-36.
119. Plummer JL, Cmielewski PL, Gourlay GK, Owen H, Cousins MJ. Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine, nor-adrenaline, carbachol or midazolam in rats. Pain 1992; 49:145-152.
120. Burton AW, Deer TR, Wallace MS, Rauck RL, Grigsby E. Considerations and methodology for trialing ziconotide. Pain Physician 2010; 16:23-33.
121. Deer TR, Kim C, Bowman R, Tolentino D, Steward C, Tolentino W. Intrathecal zi-conotide and opioid combination therapy for noncancer pain: An observational study. Pain Physician 2009; 12:E291-E296.
122. Thompson JC, Dunbar E, Laye RR. Treat-ment challenges and complications with zicontide monotherapy in established pump patients. Pain Physician 2005; 8:147-152.
123. Hassenbusch S, Burchiel K, Coffey RJ, Cousins MJ, Deer T, Hahn MB, Pen SD, Follett KA, Krames E, Rogers JN, Sagher O, Staats PS, Wallace M, Willis KD. Management of intrathecal catheter-tip inflammatory masses: A consensus statement. Pain Med 2002; 3:313-323.
124. Yennurajalingam S, Braiteh F, Bruera E. Pain and terminal delirium research in the elderly. Clin Geriatr Med 2005; 21:93-119.
125. Galloway D. Treating patients with cancer requires looking beyond the tumor. www2.mdanderson.org/depts/onco-log/articles/pf/04/7-8-julaug/7-8-04-3-pf.html. Accessed August 11, 2009.
126. Mercadante S. Controversies over spinal treatment in advanced cancer patients. Support Care Cancer 1998; 6:495-502.
127. World Health Organization. Cancer Pain Relief. Second Edition. With a Guide to Opi-oid Availability. WHO, Geneva, Switzerland, 1996, pp 36-37.
128. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001; 93:247-257.
129. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain 1995; 63:65-76.
130. Willis KD, Doleys DM. The effects of long term intraspinal infusion therapy with non-cancer pain patients: Evaluation of patient, significant-other, and clinic staff appraisals. Neuromodulation 1999; 2:241-253.
131. Onofrio BM, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg 1990; 72:200-209.
132. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981; 56:516-520.
133. Yaksh TL, Reddy SV. Studies in the primate on the analgetic effects associated with in-trathecal actions of opiates, alpha-adren-ergic agonists and baclofen. Anesthesiolo-gy 1981; 54:451-467.
134. Farney RJ, Walker JM, Cloward TV, Rhon-deau S. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003; 123:632-639.
135. Krames ES, Olson K. Clinical realities and economic considerations: Patient selection in intrathecal therapy. J Pain Symptom Manage 1997; 14:S3-S13.
136. Rozzini R, Frisoni GB, Ferrucci L, Barbi-soni P, Sabatini T, Ranieri P, Guralnik JM, Trabucchi M. Geriatric Index of Comor-bidity: Validation and comparison with other measures of comorbidity. Age Ageing 2002; 31:277-285.
137. Platelet transfusion guidelines. American Red Cross. www.newenglandblood.org/professional/plateletguide.htm. Accessed October 30, 2009.
138. Physicians' Desk Reference 62nd ed. Thomson PDR, Montvale, NJ, 2008, page 1198.
139. Risdahl JM, Khanna KV, Peterson PK, Mo-litor TW. Opiates and infection. J Neuroim-munol 1998; 83:4-18.
140. Del Pozo JL, Patel R. Clinical practice: Infection associated with prosthetic joints. N Engl J Med 2009; 361:787-794.
141. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Infection, Infection Control and Hospital Epidemiology, Vol 20, No 4, 247-278.
142. Rathmell JP, Lake T, Ramundo MB. Infectious risks of chronic pain treatments: Injection therapy, surgical implants, and in-tradiscal techniques. Reg Anesth Pain Med 2006; 31:346-352.
143. Streiff MB. Diagnosis and initial treatment of venous thromboembolism in patients with cancer. J Clin Oncol 2009; 27:4889-4894.
144. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, Yuan CS. Regional anesthesia in the an-ticoagulated patient: Defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagu-lation). Reg Anesth Pain Med 2003; 28:172-197.
145. Chaney MA. Intrathecal and epidural anesthesia and analgesia for cardiac surgery. Anesth Analg 2006; 102:45-64.
146. Preventing errors relating to commonly used anticoagulants. The Joint Commission. www.jointcommission.org/Sentine-lEvents/SentinelEventAlert/sea_41.htm. Accessed July 28, 2009.
147. Diabetes Statistics. American Diabetes Association. www.diabetes.org/diabetes-ba-sics/diabetes-statistics. Accessed November 4, 2009.
148. Diabetic neuropathies: The nerve damage of diabetes. National Diabetes Information Clearinghouse (NDIC). diabetes.nid-dk.nih.gov/dm/pubs/neuropathies/index. htm. Accessed July 28, 2009.
149. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293:194-202.
150. Greenhalgh DG. Wound healing and diabetes mellitus. Clin Plast Surg 2003; 30:37-45.
151. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195.
152. Ogden CL, Carrol MD, McDowell MA, Flegal KM. Obesity among adults in the United States-no statistically significant chance since 2003-2004. NCHS Data Brief 2007; 1:1-8.
153. Obstructive sleep apnea and sleep. National Sleep Foundation. www.sleepfoun-dation.org/article/sleep-related-prob-lems/obstructive-sleep-apnea-and-sleep. Accessed August 11, 2009.
154. Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008; 9:425-432.
155. American Society of Anesthesiologists Task Force on Neuraxial Opioids, Hor-locker TT, Burton AW, Connis RT, Hughes SC, Nickinovich DG, Palmer CM, Pollock JE, Rathmell JP, Rosequist RW, Swisher JL, Wu CL. Practice guidelines for the prevention, detection, and management of respiratory depression associated with neur-axial opioid administration. Anesthesiology 2009; 110:218-230.
156. Pergolizzi J, Boger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Opioids and the management of chronic severe pain in the elderly: Consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization step III opioids (bu-prenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008; 8:287-313.
157. Berger NA, Savvides P, Koroukian SM, Ka-hana EF, Deimling GT, Rose JH, Bowman KF, Miller RH. Cancer in the elderly. Trans Am Clin Climatol Assoc 2006; 117:147-155.
158. Urban D, Cherny N, Catane R. The management of cancer pain in the elderly. Crit Rev Oncol Hematol 2010; 73:176-183.
159. Stein WM, Miech RP. Cancer pain in the elderly hospice patient. J Pain Symptom Manage 1993; 8:474-482.
160. Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP. Age-dependent opioid escalation in chronic pain patients. Anesth Analg 2005;100: 1740-1745.
161. National diabetes fact sheet, 2007. Centers for Disease Control and Prevention. www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed August 11, 2009.
162. Cancer Facts and Figures 2003. American Cancer Society. www.cancer.org/down-loads/STT/CAFF2003PWSecured.pdf. Accessed October 15, 2009.
163. Turk DC, Monarch ES, Williams AD. Cancer patients with pain: Considerations for assessing the whole person. Hematological Oncol Clin N Am 2002; 16:511-525.
164. Kroner K, Krebs B, Skov J, Jorgensen HS. Immediate and long term phantom breast syndrome after mastectomy: Incidence, clinical characteristic relationship to pre-mastectomy breast pain. Pain 1989; 36:327-335.
165. Barkwell DP. Ascribed meaning: A critical factor in coping and pain attenuation in patients with cancer-related pain. J Palliat Care 1991; 7:5-14.
166. Spiegel D, Bloom JR. Group therapy and hypnosis reduced metastatic breast carcinoma pain. Psychosom Med 1982; 45:333-339.
167. Ahles TA, Blanchard EB, Ruckdeschel JC. The multidimensional nature of cancer-related pain. Pain 1983; 17:277-288.
168. Zaza C, Baine N. Cancer pain and psychological factors: A critical review of the literature. J Pain Symptom Manage 2002; 24:526-542.
169. Glover J, Dibble SL, Dodd MJ, Miaskowski C. Mood states of oncological outpatients: Does pain make a difference? J Pain Symptom Manage 1995; 10:120-128.
170. Kane RL, Berstein L, Wales J, Rothenberg R. Hospice effectiveness in controlling pain. JAMA 1985; 253:2683-6.
171. Kelsen DP, Portenoy RK, Thaler HT, Niedz-wiecki D, Passik SD, Tao Y, Banks W, Bren-nan MF, Foley KM. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995; 13:748-755.
172. Steinman RH. The cancer patient with anxiety and chronic pain. Pain: Clinical Updates 2009; 27:1-5.
173. Monroe B. Psychological evaluation of patient and family. In Sykes N, Fallon MT, Patt RB (eds). Clinical Pain Management: Cancer Pain. Oxford University Press, New York, New York, 2003, pp 73-85.
174. Rathbone GV, Horsley S, Goacher J. A self-evaluated assessment suitable for seriously ill hospice patients. Palliat Med 1994; 8:29-34.
175. Endicott J. Measurement of depression in patients with cancer. Cancer 1984; 53:2243-2249.
176. Casey P. Depression in the dying-disorder or distress? Prog Palliative Care 1994; 2:1-3.
177. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B, Bliss J. The factor structure and factor stability of the Hospital Anxiety and Depression Scale with cancer. Br J Psychiatry 1991; 158:255-259.
178. Daunt RJ, Cleeland CS, Flannery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17:197-210.
179. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1948; 1:634-656.
180. Ware JE, Kosinki M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. The Health Institue, Boston, Massachusetts, 1994.
181. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55.
182. Derogatis LR, Morow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Hen-richs M, Carnicke CL Jr. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249:751-757.
183. Massie MJ, Holloand JC. The cancer patient with pain: Psychiatric complications and their management. J Pain Symptom Manage 1992; 7:99-109.
184. Asmundson GJ, Coons MJ, Taylor S, Katz J. PTSD and the experience of pain: Research and clinical implications of shared vulnerability and mutual maintenance models. Can J Psychiatry 2002; 47:930-937.
185. Keogh E, Cochrane M. Anxiety sensitivity, coping biases and the experience of pain. J Pain 2002; 3:320-329.
186. Miller K, Massie MJ. Depression and anxiety. Cancer J 2006; 12:388-397.
187. Cahana A. Is optimal pain relief always optimal? APS Bull 2002; 12:3.
188. Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Pawlik-Plank D, Rob-bins A, Stormoen D, Weissman DE. Patient-related barriers to management of cancer pain. Pain 1993; 52:319-324.
189. Ward SE, Carlson-Dakes K, Hughes SH, Kwekkeboom KL, Donovan HS. The impact of quality of life on patient-related barriers to pain management. Res Nurs Health 1998; 21:5-13.
190. Ahmed SU, Martin NM, Chang Y. Patient selection and trial methods for intraspinal drug delivery for chronic pain: A national survey. Neuromodulation 2005; 8:112-120.
191. Keefe FJ, Abernethy AP, Campbell L. Psychological approaches to understanding and treating disease-related pain. Annu Rev Psychol 2005; 56:601-630.
192. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: A new frontier. Pain Med 2007; 8:189-198.
193. Deer T, Ranson M, Stewart D. Relevant anatomy for spinal delivery. In: Krames E, Hunter Peckham P, Rezai A (eds). Neuro-modulation. Elsevier, New York, New York, 2009.
194. Follett KA, Burchiel K, Deer T, Stuart DuPen, Joshua Prager, Michael S. Turner and Robert J. Coffey. Prevention of intra-thecal drug delivery catheter-related complications. Neuromodulation 2003; 6:32-41.
195. Carr DB, Cousins MJ. Spinal route of analgesia: Opioids and future options for spinal analgesic chemotherapy. In: Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO (eds). Neural Blockade in Clinical Anesthesia and Pain Medicine 4th ed. Wolt-ers Kluwer Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, 2008, pp 886-947.
196. Relative survival rates by year of diagnosis. National Cancer Institute. seer.cancer. gov/csr/1975_2005/results_merged/topic_ survival_by_year_dx.pdf. Accessed October 7, 2009.
197. Levy MH, Chwistek M, Mehta RS. Management of chronic pain in cancer survivors. Cancer J 2008; 14:401-409.
198. Abernethy AP, Wheeler JL, Fortner BV. A health economic model of breakthrough pain. Am J Manag Care 2008; 14:S129-S140.
199. Prescription Price Center (2009). www.drugstore.com/pharmacy/drugindex. Accessed April 3, 2009.
200. Intrathecal drug delivery for chronic pain: Physician commonly billed codes. Medtronic for Healthcare Professionals. (January 2009). professional.medtronic.com/downloads/idd/idd-physician-com-mon-codes.pdf. Accessed April 15, 2009.
201. Intrathecal drug delivery for chronic pain: Hospital commonly billed codes. Medtronic for Healthcare Professionals. (January 2009). professional.medtronic.com/downloads/idd/idd-hospital-com-mon-codes.pdf. Accessed April 15, 2009.
202. Medicare Part B Drug Average Sales Price. 2009 ASP Drug Pricing Files. Centers for Medicare & Medicaid Services. www.cms.hhs.gov/McrPartBDrugAvgSalesPrice. Accessed April 21, 2009.
203. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 1991; 6:368-373.
204. De Lissovoy G, Brown RE, Halpern M, Hassenbusch SJ, Ross E. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther 1997; 19:96-112.
205. Federal Register. Hospital outpatient rates. Volume 73, Number 193, October 3, 2008.
206. Federal Register. Physician rates. Volume 73, Number 224, November 19, 2008.
207. Deer TR, Smith HS, Cousins M, Doleys DM, Levy RM, Rathmell JP, Staats PS, Wallace M, Webster LR. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Med Unpublished data. In press.
208. Actiq. Drugstore.com. http://www.drug-store.com/pharmacy/prices/drugprice.asp?ndc=63459050430&trx=1Z5006. Accessed October 30, 2009.
209. PMA-premarket approval. US Food and Drug Administration. www.accessdata. fda.gov/scripts/cdrh/cfdocs/cfPMA/PMA.cfm?ID=4499. Accessed May 8, 2009.
210. Rainov NG, Buchser E. Making a case for programmable pumps over fixed rate pumps for the management of fluctua-tions in chronic pain and spasticity: A literature review. Neuromodulation 2002; 5:89-99.
211. Ilias W, Todoroff B. Optimizing pain control through the use of implantable pumps. Medical Devices: Evidence and Research 2008; 1:41-47.
212. Prager J, Jacobs M. Evaluation of patients for implantable pain modalities: Medical and behavioral assessment. Clin J Pain 2001; 17:206-214.
213. Levy RM. Quantitative, crossover, double-blind trial paradigm for patient screening for chronic intraspinal narcotic administration. Neurosurg Focus 1997; 2:e2.
214. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: Relationship to patient characteristics and current adjustment. Pain 1983; 17:33-44.
215. Dominguez E, Sahinler B, Bassam D, Day M, Lou L, Racz G, Raj P. Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain patients. Pain Pract 2002; 2:315-325.
216. Hassenbusch SJ, Stanton-Hicks M, Cov-ington EC, Walsh JG, Guthrey DS. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995; 10:527-543.
217. Yoshida GM, Nelson RW, Capen DA, Nagelberg S, Thomas JC, Rimoldi RL, Haye W. Evaluation of continuous intra-spinal narcotic analgesia for chronic pain from benign causes. Am J Orthop (Belle Meade NJ) 1996; 25:693-694.
218. Follett KA, Doleys DM. Selection of candidates for intrathecal drug administration to treat chronic pain: considerations in pre-implantation trials. Minneapolis, MN: Medtronic, Inc; 2002.
219. Medicare Coverage Issues Manual. Coverage issues-durable medical equipment. www.cms.hhs.gov/manuals/downloads/Pub06_PART_60.pdf Accessed August 19, 2009.
220. Hassenbusch SJ, Portenoy RK, Cousins M, Buchser E, Deer TR, Du Pen SL, Eisenach J, Follett KA, Hildebrand KR, Krames ES, Levy RM, Palmer PP, Rathmell JP, Rauck RL, Staats PS, Stearns L, Willis KD. Poly-analgesic Consensus Conference 2003: An update on the management of pain by in-traspinal drug delivery-report of an expert panel. J Pain Symptom Manage 2004; 27:540-563.
221. Crul BJ, Delhaas EM. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: A review of 140 cases. Reg Anesth 1991; 16:209-213.
222. van Kleef M, Mekhail N, van Zundert J. Evidence based guidelines for interventional pain medicine according to clinical diagnoses. Pain Pract 2009; 9:247-251.
223. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schunemann H. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College Of Chest Physicians Task Force. Chest 2006; 129:174-181.
224. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, etal.; Committee on Standards for Systematic Reviews of Comparative Effectiveness Research; Institute of Medicine. Clinical Practice Guidelines We Can Trust. The National Academies Press, Washington, DC, 2011.
225. Eden J, Levit L, Berg A, Morton, S, (eds); Committee on Standards for Systematic Reviews of Comparative Effectiveness Research; Institute of Medicine. Finding What Works in Health Care. Standards for Systematic Reviews. The National Academies Press, Washington, DC, 2011.
226. Manchikanti L, Hirsch JA, Smith HS. Evidence-based medicine, systematic reviews, and guidelines in intervention-al pain management: Part 2: Randomized controlled trials. Pain Physician 2008; 11:717-773.
227. Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in inter-ventional pain management: Part 3: Systematic reviews and meta-analysis of randomized trials. Pain Physician 2009; 12:35-72.
228. Manchikanti L, Singh V, Smith HS, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 4: Observational studies. Pain Physician 2009; 12:73-108.
229. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 5. Diagnostic accuracy studies. Pain Physician 2009; 12:517-540.
230. Manchikanti L, Datta S, Smith HS, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 6. Systematic reviews and meta-analyses of observational studies. Pain Physician 2009; 12:819-850.
231. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 7: Systematic reviews and meta-anal-yses of diagnostic accuracy studies. Pain Physician 2009; 12:929-963.
232. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-E54.
233. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management. Pain Physician 2010; 13:E55-E79.
234. Manchikanti L, Datta S, Derby R, Wolf-er LR, Benyamin RM, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 1. Diagnostic interventions. Pain Physician 2010; 13:E141-E174.
235. Manchikanti L, Datta S, Gupta S, Mung-lani R, Bryce DA, Ward SP, Benyamin RM, Sharma ML, Helm II S, Fellows B, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for in-terventional techniques: Part 2. Therapeutic interventions. Pain Physician 2010; 13:E215-E264.
236. Benyamin RM, Datta S, Falco FJE. A perfect storm in interventional pain management: Regulated, but unbalanced. Pain Physician 2010; 13:109-116.
237. Manchikanti L, Singh V, Boswell MV. In-terventional pain management at crossroads: The perfect storm brewing for a new decade of challenges. Pain Physician 2010; 13:E111-E140.
238. Manchikanti L, Singh V, Pampati V, Smith HS, Hirsch JA. Analysis of growth of inter-ventional techniques in managing chronic pain in Medicare population: A 10-year evaluation from 1997 to 2006. Pain Physician 2009; 12:9-34.
239. Manchikanti L, Pampati V, Singh V, Bo-swell MV, Smith HS, Hirsch JA. Explosive growth of facet joint interventions in the Medicare population in the United States: A comparative evaluation of 1997, 2002, and 2006 data. BMC Health Serv Res 2010; 10:84.
240. Manchikanti L, Pampati V, Boswell MV, Smith HS, Hirsch JA. Analysis of the growth of epidural injections and costs in the Medicare population: A comparative evaluation of 1997, 2002, and 2006 data. Pain Physician 2010; 13:199-212.